Albemarle Corporation ALB
Verdict: Sell. Fair value $107 against a price of $144 on 5 Jan 2026, 26% below the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins.
Main risks
- Severe revenue contraction (-44% YoY) driven by cyclical commodity pricing collapse
- Profitability deterioration with Net Income swinging from $2.7B profit to $1.18B loss
- Negative incremental returns on capital (ROIIC -31%) indicating recent capital deployment has destroyed value during the downturn
- Near-term debt maturity concerns
- Intense competitive environment